Apollomics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Selling, General & Admin	20.64	9.95	15.29	11.04
Research & Development	34.19	35.46	35.57	31.44
Other Operating Expenses	44.79	5.16	6.47	2.1
Operating Expenses	99.62	50.57	57.33	44.59
Operating Income	-99.62	-50.57	-57.33	-44.59
Interest Expense / Income	0.15	0.09	0.08	0.07
Other Expense / Income	72.82	190.15	37.39	30.25
Pretax Income	-172.59	-240.81	-94.8	-74.91
Income Tax	0.01	0	0	-0.09
Net Income	-172.6	-240.81	-94.8	-74.82
Shares Outstanding (Basic)	89	13	6	-
Shares Change	566.40%	113.64%	-	-
EPS (Basic)	-2.32	-8.44	-3.37	-0.21
EPS (Diluted)	-2.32	-8.44	-3.37	-0.21
Free Cash Flow	-43.15	-43.25	-43.36	-35.83
Free Cash Flow Per Share	-0.48	-3.22	-6.90	-
EBITDA	-171.77	-239.94	-94.03	-74.22
Depreciation & Amortization	0.67	0.78	0.68	0.61
EBIT	-172.44	-240.72	-94.71	-74.83

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).